tiprankstipranks
Syros Pharmaceuticals (SYRS)
NASDAQ:SYRS

Syros Pharmaceuticals (SYRS) Technical Analysis

878 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
4Neutral
6Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Syros Pharmaceuticals’s (SYRS) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Syros Pharmaceuticals is a Sell.
Syros Pharmaceuticals’s (SYRS) 20-Day exponential moving average is 5.25, while Syros Pharmaceuticals’s (SYRS) share price is $5.45, making it a Buy.
Syros Pharmaceuticals’s (SYRS) 50-Day exponential moving average is 5.51, while Syros Pharmaceuticals’s (SYRS) share price is $5.45, making it a Sell.

Syros Pharmaceuticals (SYRS) Pivot Points

May 18, 2024, 12:09 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.79
5.08
5.29
5.58
5.79
6.08
6.29
Fibonacci
5.08
5.27
5.39
5.58
5.77
5.89
6.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Syros Pharmaceuticals (SYRS) Moving Averages

May 18, 2024, 12:09 AM
Period
Simple
Exponential
MA5
5.29Buy
5.35Buy
MA10
5.18Buy
5.26Buy
MA20
5.16Buy
5.25Buy
MA50
5.50Sell
5.51Sell
MA100
6.33Sell
5.55Sell
MA200
4.88Buy
4.79Buy
Syros Pharmaceuticals’s (SYRS) 10-Day exponential moving average is 5.26, while Syros Pharmaceuticals’s (SYRS) share price is $5.45, making it a Buy.
Syros Pharmaceuticals’s (SYRS) 100-Day exponential moving average is 5.55, while Syros Pharmaceuticals’s (SYRS) share price is $5.45, making it a Sell.
Syros Pharmaceuticals’s (SYRS) stock price is $5.45 and Syros Pharmaceuticals’s (SYRS) 50-day simple moving average is 5.50, creating a Sell signal.
Syros Pharmaceuticals’s (SYRS) stock price is $5.45 and Syros Pharmaceuticals’s (SYRS) 100-day simple moving average is 6.33, creating a Sell signal.
Syros Pharmaceuticals’s (SYRS) stock price is $5.45 and Syros Pharmaceuticals’s (SYRS) 200-day simple moving average is 4.88, creating a Buy signal.

Syros Pharmaceuticals (SYRS) Technical Indicators

May 18, 2024, 12:09 AM
Name
Value
Implied Action
RSI (14)
54.58
Neutral
STOCH (9,6)
65.19
Neutral
STOCHRSI (14)
64.91
Neutral
MACD (12,26)
-0.04
Sell
ADX (14)
15.67
Buy
Williams %R
-39.58
Buy
CCI (14)
119.34
Sell
ATR (14)
0.35
-
Ultimate Oscillator
42.43
Neutral
ROC
8.73
Buy
Syros Pharmaceuticals’s (SYRS) Relative Strength Index (RSI) is 54.58, creating a Neutral signal.
Syros Pharmaceuticals’s (SYRS) Trend Strength Indicator (ADX) is 15.67, creating a Buy signal.
Syros Pharmaceuticals’s (SYRS) Commodity Channel Index (CCI) is 119.34, creating a Sell signal.
Syros Pharmaceuticals’s (SYRS) Price Rate of Change (ROC) is 8.73, creating a Buy signal.

FAQ

Is SYRS a Buy, Hold, or Sell?
Based on SYRS’s technical indicators, SYRS is a Buy.
    What is SYRS’s RSI (14)?
    SYRS’s RSI (14) is 54.58, which suggests SYRS is a Neutral.
      What is SYRS’s MACD?
      SYRS’s MACD is -0.04, which suggests SYRS is a Sell.
        What is SYRS’s 5-day moving average?
        SYRS’s 5-day moving average is 5.29, which suggests SYRS is a Buy.
          What is SYRS’s 20-day moving average?
          SYRS 20-day moving average is 5.16, which suggests SYRS is a Buy.
            What is SYRS’s 50-day moving average?
            SYRS’s 50-day moving average is 5.50, which suggests SYRS is a Sell.
              What is SYRS’s 200-day moving average?
              SYRS’s 200-day moving average is 4.88, which suggests SYRS is a Buy.
                What is SYRS’s Williams % R (14)?
                SYRS’s Williams % R (14) is -39.58, which suggests SYRS is a Buy.
                  What is SYRS’s CCI (14)?
                  SYRS’s CCI (14) is 119.34, which suggests SYRS is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis